Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Reiss

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Social Science & Medicine (1982)|January 9, 2017
Is it time to talk? Understanding specialty child mental healthcare providers' decisions to engage in interdisciplinary communication with pediatriciansMichael Reiss, Carolyn A Greene, Julian D Ford
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximabRegina Loomis, Rocco Carbone, Michael Reiss, et al.
Cancer Research|March 15, 2008
Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotypeSavita Bharathy, Wen Xie, Jonathan M Yingling, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 30, 2007
A clinically motivated 2-fold framework for quantifying and classifying immunohistochemically stained specimensBonnie Hall, Wenjin Chen, Michael Reiss, et al.
The Journal of Biological Chemistry|July 24, 2003
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2Kyung Song, Susan C Cornelius, Michael Reiss, et al.
The Journal of Biological Chemistry|February 26, 2004
Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2Nagarajan Selvamurugan, Sukyee Kwok, Tamara Alliston, et al.
Cancer Informatics|December 17, 2008
Decentralized data sharing of tissue microarrays for investigative research in oncologyWenjin Chen, Cristina Schmidt, Manish Parashar, et al.
Cancer Practice|March 21, 2002
A young woman with recurrence of breast cancerCarole Martz, Bruce G Haffy, Barbara Ward, et al.
The Journal of Biological Chemistry|October 23, 2001
Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan functionOliver Eickelberg, Michael Centrella, Michael Reiss, et al.
Experimental Cell Research|August 28, 2007
Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbetaBradley Yates, Craig Zetterberg, Vaishali Rajeev, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Social Science & Medicine (1982)|January 9, 2017
Is it time to talk? Understanding specialty child mental healthcare providers' decisions to engage in interdisciplinary communication with pediatriciansMichael Reiss, Carolyn A Greene, Julian D Ford
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximabRegina Loomis, Rocco Carbone, Michael Reiss, et al.
Cancer Research|March 15, 2008
Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotypeSavita Bharathy, Wen Xie, Jonathan M Yingling, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 30, 2007
A clinically motivated 2-fold framework for quantifying and classifying immunohistochemically stained specimensBonnie Hall, Wenjin Chen, Michael Reiss, et al.
The Journal of Biological Chemistry|July 24, 2003
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2Kyung Song, Susan C Cornelius, Michael Reiss, et al.
The Journal of Biological Chemistry|February 26, 2004
Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2Nagarajan Selvamurugan, Sukyee Kwok, Tamara Alliston, et al.
Cancer Informatics|December 17, 2008
Decentralized data sharing of tissue microarrays for investigative research in oncologyWenjin Chen, Cristina Schmidt, Manish Parashar, et al.
Cancer Practice|March 21, 2002
A young woman with recurrence of breast cancerCarole Martz, Bruce G Haffy, Barbara Ward, et al.
The Journal of Biological Chemistry|October 23, 2001
Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan functionOliver Eickelberg, Michael Centrella, Michael Reiss, et al.
Experimental Cell Research|August 28, 2007
Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbetaBradley Yates, Craig Zetterberg, Vaishali Rajeev, et al.
Pageof 12